Development-stage biopharmaceutical company that acquires promising therapeutic small molecules and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies.
DARA BioSciences, Inc. is a Raleigh, North Carolina based development-stage biopharmaceutical company that acquires promising therapeutic small molecules and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies. The company continues
... moreto build a diverse pipeline, including candidates for the treatment of metabolic diseases (diabetes), and pain. Presently DARA has two drug candidates with cleared IND’s (Investigational New Drug) Applications from the US FDA. One of these drug candidates KRN5500 has successfully completed a Phase 2a clinical trial treating cancer patients for neuropathic pain. It has a portfolio of drug candidates for neuropathic pain, type 2 diabetes, and psoriasis.less
Safe Harbor Statement
All statements in this news release that are not historical are forward-looking statements within...
more
ProActive Capital Resources Group
jramson@proactivecrg.com
8601 Six Forks Rd., Ste. 160
Raleigh, NC, 27615
United States of America